How much do you agree with the following statements? *

	Strongly disagree	Disagree	Slightly disagree	Neither	Slightly agree	Agree	Strongly agree
The activity presented balanced, evidence-based content free of commercial bias.	The activity presented balanced, evidence-based content free of commercial bias. - Strongly disagree	The activity presented balanced, evidence-based content free of commercial bias. - Disagree	The activity presented balanced, evidence-based content free of commercial bias. - Slightly disagree	The activity presented balanced, evidence-based content free of commercial bias. - Neither	The activity presented balanced, evidence-based content free of commercial bias. - Slightly agree	The activity presented balanced, evidence-based content free of commercial bias. - Agree	The activity presented balanced, evidence-based content free of commercial bias. - Strongly agree
The presenter(s) used an effective teaching strategy.	The presenter(s) used an effective teaching strategy. - Strongly disagree	The presenter(s) used an effective teaching strategy. - Disagree	The presenter(s) used an effective teaching strategy. - Slightly disagree	The presenter(s) used an effective teaching strategy. - Neither	The presenter(s) used an effective teaching strategy. - Slightly agree	The presenter(s) used an effective teaching strategy. - Agree	The presenter(s) used an effective teaching strategy. - Strongly agree
The presentation slides / digital materials / resources and handouts were high quality.	The presentation slides / digital materials / resources and handouts were high quality. - Strongly disagree	The presentation slides / digital materials / resources and handouts were high quality. - Disagree	The presentation slides / digital materials / resources and handouts were high quality. - Slightly disagree	The presentation slides / digital materials / resources and handouts were high quality. - Neither	The presentation slides / digital materials / resources and handouts were high quality. - Slightly agree	The presentation slides / digital materials / resources and handouts were high quality. - Agree	The presentation slides / digital materials / resources and handouts were high quality. - Strongly agree
The content was relevant to / useful for my professional practice.	The content was relevant to / useful for my professional practice. - Strongly disagree	The content was relevant to / useful for my professional practice. - Disagree	The content was relevant to / useful for my professional practice. - Slightly disagree	The content was relevant to / useful for my professional practice. - Neither	The content was relevant to / useful for my professional practice. - Slightly agree	The content was relevant to / useful for my professional practice. - Agree	The content was relevant to / useful for my professional practice. - Strongly agree
The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care.	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Strongly disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Slightly disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Neither	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Slightly agree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Agree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Strongly agree
The overall quality of the educational activity was excellent.	The overall quality of the educational activity was excellent. - Strongly disagree	The overall quality of the educational activity was excellent. - Disagree	The overall quality of the educational activity was excellent. - Slightly disagree	The overall quality of the educational activity was excellent. - Neither	The overall quality of the educational activity was excellent. - Slightly agree	The overall quality of the educational activity was excellent. - Agree	The overall quality of the educational activity was excellent. - Strongly agree

The activity successfully achieved its learning objectives by enhancing my ability to: *

	Strongly disagree	Disagree	Slightly disagree	Neither	Slightly agree	Agree	Strongly agree
1. Identify cellular microbiology content and processes.	1. Identify cellular microbiology content and processes. - Strongly disagree	1. Identify cellular microbiology content and processes. - Disagree	1. Identify cellular microbiology content and processes. - Slightly disagree	1. Identify cellular microbiology content and processes. - Neither	1. Identify cellular microbiology content and processes. - Slightly agree	1. Identify cellular microbiology content and processes. - Agree	1. Identify cellular microbiology content and processes. - Strongly agree
2. Explain the pharmacogenomics (PGx) field.	2. Explain the pharmacogenomics (PGx) field. - Strongly disagree	2. Explain the pharmacogenomics (PGx) field. - Disagree	2. Explain the pharmacogenomics (PGx) field. - Slightly disagree	2. Explain the pharmacogenomics (PGx) field. - Neither	2. Explain the pharmacogenomics (PGx) field. - Slightly agree	2. Explain the pharmacogenomics (PGx) field. - Agree	2. Explain the pharmacogenomics (PGx) field. - Strongly agree
3. Describe pharmacokinetic/pharmacodynamics principles and application to drug absorption, distribution, metabolism and elimination (ADME) involved in PGx.	3. Describe pharmacokinetic/pharmacodynamics principles and application to drug absorption, distribution, metabolism and elimination (ADME) involved in PGx. - Strongly disagree	3. Describe pharmacokinetic/pharmacodynamics principles and application to drug absorption, distribution, metabolism and elimination (ADME) involved in PGx. - Disagree	3. Describe pharmacokinetic/pharmacodynamics principles and application to drug absorption, distribution, metabolism and elimination (ADME) involved in PGx. - Slightly disagree	3. Describe pharmacokinetic/pharmacodynamics principles and application to drug absorption, distribution, metabolism and elimination (ADME) involved in PGx. - Neither	3. Describe pharmacokinetic/pharmacodynamics principles and application to drug absorption, distribution, metabolism and elimination (ADME) involved in PGx. - Slightly agree	3. Describe pharmacokinetic/pharmacodynamics principles and application to drug absorption, distribution, metabolism and elimination (ADME) involved in PGx. - Agree	3. Describe pharmacokinetic/pharmacodynamics principles and application to drug absorption, distribution, metabolism and elimination (ADME) involved in PGx. - Strongly agree
4. Organize PGx-specific tools/resources.	4. Organize PGx-specific tools/resources. - Strongly disagree	4. Organize PGx-specific tools/resources. - Disagree	4. Organize PGx-specific tools/resources. - Slightly disagree	4. Organize PGx-specific tools/resources. - Neither	4. Organize PGx-specific tools/resources. - Slightly agree	4. Organize PGx-specific tools/resources. - Agree	4. Organize PGx-specific tools/resources. - Strongly agree
5. Develop a plan for further pharmacist training and use of core competencies.	5. Develop a plan for further pharmacist training and use of core competencies. - Strongly disagree	5. Develop a plan for further pharmacist training and use of core competencies. - Disagree	5. Develop a plan for further pharmacist training and use of core competencies. - Slightly disagree	5. Develop a plan for further pharmacist training and use of core competencies. - Neither	5. Develop a plan for further pharmacist training and use of core competencies. - Slightly agree	5. Develop a plan for further pharmacist training and use of core competencies. - Agree	5. Develop a plan for further pharmacist training and use of core competencies. - Strongly agree
6. Describe varying practice models.	6. Describe varying practice models. - Strongly disagree	6. Describe varying practice models. - Disagree	6. Describe varying practice models. - Slightly disagree	6. Describe varying practice models. - Neither	6. Describe varying practice models. - Slightly agree	6. Describe varying practice models. - Agree	6. Describe varying practice models. - Strongly agree
7. Evaluate clinical protocols for application.	7. Evaluate clinical protocols for application. - Strongly disagree	7. Evaluate clinical protocols for application. - Disagree	7. Evaluate clinical protocols for application. - Slightly disagree	7. Evaluate clinical protocols for application. - Neither	7. Evaluate clinical protocols for application. - Slightly agree	7. Evaluate clinical protocols for application. - Agree	7. Evaluate clinical protocols for application. - Strongly agree
8. Analyze CYP 2C19 and clopidogrel specific guideline.	8. Analyze CYP 2C19 and clopidogrel specific guideline. - Strongly disagree	8. Analyze CYP 2C19 and clopidogrel specific guideline. - Disagree	8. Analyze CYP 2C19 and clopidogrel specific guideline. - Slightly disagree	8. Analyze CYP 2C19 and clopidogrel specific guideline. - Neither	8. Analyze CYP 2C19 and clopidogrel specific guideline. - Slightly agree	8. Analyze CYP 2C19 and clopidogrel specific guideline. - Agree	8. Analyze CYP 2C19 and clopidogrel specific guideline. - Strongly agree
9. Analyze the newly updated G6PD-specific guidelines, and current system alerts.	9. Analyze the newly updated G6PD-specific guidelines, and current system alerts. - Strongly disagree	9. Analyze the newly updated G6PD-specific guidelines, and current system alerts. - Disagree	9. Analyze the newly updated G6PD-specific guidelines, and current system alerts. - Slightly disagree	9. Analyze the newly updated G6PD-specific guidelines, and current system alerts. - Neither	9. Analyze the newly updated G6PD-specific guidelines, and current system alerts. - Slightly agree	9. Analyze the newly updated G6PD-specific guidelines, and current system alerts. - Agree	9. Analyze the newly updated G6PD-specific guidelines, and current system alerts. - Strongly agree
10. Apply resources to patient case examples (CPIC, PharmGKB).	10. Apply resources to patient case examples (CPIC, PharmGKB). - Strongly disagree	10. Apply resources to patient case examples (CPIC, PharmGKB). - Disagree	10. Apply resources to patient case examples (CPIC, PharmGKB). - Slightly disagree	10. Apply resources to patient case examples (CPIC, PharmGKB). - Neither	10. Apply resources to patient case examples (CPIC, PharmGKB). - Slightly agree	10. Apply resources to patient case examples (CPIC, PharmGKB). - Agree	10. Apply resources to patient case examples (CPIC, PharmGKB). - Strongly agree
11. Summarize the Implementation Toolkit resources.	11. Summarize the Implementation Toolkit resources. - Strongly disagree	11. Summarize the Implementation Toolkit resources. - Disagree	11. Summarize the Implementation Toolkit resources. - Slightly disagree	11. Summarize the Implementation Toolkit resources. - Neither	11. Summarize the Implementation Toolkit resources. - Slightly agree	11. Summarize the Implementation Toolkit resources. - Agree	11. Summarize the Implementation Toolkit resources. - Strongly agree

What do you anticipate changing or how will you apply what you learned in your professional practice? *

How will you apply what you learned when working with providers of other disciplines or members of your interprofessional healthcare team? *

What barriers, if any, do you see to implementing these changes? *

Please provide feedback on your experience navigating this website and completing the CE process. *

Based on your educational needs, what topics would you like to see addressed in future educational activities? *

Please discuss any additional concerns or comments about this program and indicate whether the program met your expectations. *

attestation checkbox *

I completed this educational activity independently and in its entirety.

Leave this field blank